
The primary focus of Dr. Luks's current research program is to use advanced neuroimaging to advance our ability to optimize treatment for patients with neurological and psychiatric disorders by predicting and monitoring disease progression, treatment response, cognitive function, and quality of life (QoL) in these patients. In subjects with psychiatric disorders, the goal of the research is to understand the biological mechanisms of impairment and guide and evaluate behavioral and pharmacological interventions with functional neuroimaging. This translational research program employs structural imaging and connectivity (anatomical MRI and DTI), functional neuroimaging and connectivity (fMRI), positron emission tomography (PET), and measures of neurocognitive and neurological status. Dr. Luks has conducted MRI, fMRI, and magnetoencephalography (MEG) studies of the neurobiological bases of cognitive functions in health control subjects, in patients with Depression, Autism, Glioma, Schizophrenia, Dementia, TBI, and in normal adolescents and aging.